|
Participant characteristics |
||||
| Mean |
SD |
Range |
||
|
|
||||
| Male/Female, n |
14/22 |
|||
| Type of stroke, n |
||||
| Ischemic/Hemorrhagic/Unknown |
25/10/1 |
|||
| Hemiparetic side, n |
||||
| Right/Left/Bilateral |
17/17/2 |
|||
| Medications |
||||
| β-blockers/ACE inhibitors/None/Both |
6/17/11/2 |
|||
| Co-morbidities |
||||
| Hypertension |
25 |
|||
| Cholesteremia |
12 |
|||
| Diabetes mellitus |
4 |
|||
| Coronary artery disease |
8 |
|||
| Chronic obstructive pulmonary disease |
3 |
|||
| History of smoking |
11 |
|||
| Age, years |
64.6 |
14.4 |
19–90 |
|
| National Institutes of Health Stroke Scale* |
2.8 |
2.3 |
0–10 |
|
| Chedoke-McMaster Stroke Assessment Leg score |
5.1 |
1.0 |
4–7 |
|
| Functional Independence Measure |
110.8 |
9.2 |
77–125 |
|
|
* Data missing for 6 participants | ||||
Tang et al. Journal of NeuroEngineering and Rehabilitation 2006 3:23 doi:10.1186/1743-0003-3-23 |
||||